autologous genetically modified human dermal fibroblasts

autologous genetically modified human dermal fibroblasts
Trade Name
Orphan Indication Dystrophic epidermolysis bullosa
USA Market Approval USA
USA Designation Date 2014-06-10 00:00:00
Sponsor Fibrocell Technologies, Inc.;405 Eagleview Blvd;Exton, Pennsylvania, 19341